Synmosa Biopharma Corporation (4114.TWO)

TWD 33.45

(0.0%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 11.72 Billion 11.2 Billion 10.31 Billion 10.37 Billion 8.72 Billion
Total Current Assets 4.53 Billion 4 Billion 3.09 Billion 2.98 Billion 2.31 Billion
Cash And Short Term Investments 1.65 Billion 1.41 Billion 993.12 Million 745.35 Million 573.1 Million
Cash and Cash Equivalents 918.55 Million 1.08 Billion 868.16 Million 638.34 Million 468.1 Million
Short Term Investments 736.33 Million 331.68 Million 124.96 Million 107 Million 105 Million
Net Receivables 1.28 Billion 1.28 Billion 923.65 Million 1.03 Billion 701.27 Million
Inventory 1.59 Billion 1.3 Billion 1.17 Billion 1.19 Billion 995.28 Million
Other Current Assets 2.12 Million 1.04 Million 7.19 Million 4.75 Million 145 Thousand
Total Non-Current Assets 7.18 Billion 7.19 Billion 7.21 Billion 7.39 Billion 6.41 Billion
Net PPE 5.55 Billion 5.63 Billion 5.66 Billion 5.78 Billion 4.95 Billion
Good Will And Intangible Assets 558.84 Million 567.87 Million 501.3 Million 549.96 Million 580.7 Million
Good Will 62.28 Million 71.08 Million 7.27 Million - 20.8 Million
Intangible Assets 496.56 Million 496.79 Million 494.03 Million - 559.89 Million
Long-Term Investments -513.45 Million -108.67 Million 178.52 Million 172.82 Million 601.84 Million
Tax Assets 330.56 Million 331.78 Million 329.28 Million 311.69 Million 242.55 Million
Other Non Current Assets 1.25 Billion 765.2 Million 546.49 Million 572.41 Million 41 Million
Other Assets - - - - -
Total Liabilities 3.62 Billion 4.55 Billion 4.22 Billion 4.42 Billion 3.91 Billion
Total Current Liabilities 2.11 Billion 2.32 Billion 1.88 Billion 1.55 Billion 2.19 Billion
Account Payables 420.28 Million 429.68 Million 248.6 Million 183.4 Million 305.63 Million
Tax Payables 118.29 Million 95.54 Million 53.17 Million 54.6 Million -
Short Term Debt 981.15 Million 1.2 Billion 1.18 Billion 894.97 Million 1.55 Billion
Deferred Revenue 706.73 Million 681.86 Million 448.16 Million 475.72 Million 100.12 Million
Other Current Liabilities 10.24 Million 9.47 Million 6.71 Million 5.55 Million 236.04 Million
Total Non Current Liabilities 1.5 Billion 2.23 Billion 2.33 Billion 2.86 Billion 1.71 Billion
Long-Term Debt 1.45 Billion 2.16 Billion 2.27 Billion 2.8 Billion 1.65 Billion
Deferred Revenue Non Current 2.34 Million 13.88 Million 19.18 Million - 8.14 Million
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 12.76 Million 12.61 Million 886 Thousand 20.65 Million 41.55 Million
Other Liabilities - - - - -
Total Equity 8.1 Billion 6.64 Billion 6.09 Billion 5.95 Billion 4.81 Billion
Stock Holders Equity 6.7 Billion 5.31 Billion 4.7 Billion 4.5 Billion 3.48 Billion
Common Stock 4.01 Billion 3.43 Billion 3.13 Billion 2.8 Billion 2.44 Billion
Retained Earnings 813.91 Million 812.67 Million 441.78 Million 627.02 Million 679.42 Million
Accumulated other comprehensive income 397.77 Million - - - 471.59 Million
Common Stock Equity 6.7 Billion 5.31 Billion 4.7 Billion 4.5 Billion 3.48 Billion
Capital Lease Obligation 81.95 Million 65.12 Million 13.49 Million 10.66 Million -
Total Investments 222.87 Million 223 Million 303.48 Million 279.83 Million 706.84 Million
Total Debt 2.43 Billion 3.37 Billion 3.46 Billion 3.7 Billion 3.21 Billion
Net Debt 1.52 Billion 2.28 Billion 2.59 Billion 3.06 Billion 2.74 Billion

Balance Sheet Charts